GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.71 Cr | ₹3.73 Cr | ₹4.03 Cr | ₹4.00 Cr | ₹3.88 Cr |
What is the latest Contingent Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.71 Cr |
| Mar2024 | ₹3.73 Cr |
| Mar2023 | ₹4.03 Cr |
| Mar2022 | ₹4.00 Cr |
| Mar2021 | ₹3.88 Cr |
How is Contingent Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.71 Cr | 26.36 | |
| Mar2024 | ₹3.73 Cr | -7.56 | |
| Mar2023 | ₹4.03 Cr | 0.98 | |
| Mar2022 | ₹4.00 Cr | 3.10 | |
| Mar2021 | ₹3.88 Cr | - | |
Compare Contingent Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,652.6 Cr | 7% | -1.7% | 31.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 7% |
-1.7% |
31.4% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses